Why is intravenous chemotherapy cancelled and how often. Could it be prevented? A prospective analysis of all planned and given intravenous anti-tumor treatments at the Department of Oncology, Karolinska University Hospital, Stockholm during one month

References

• Garg R, Bhalotra AR, Bhadoria P, Gupta N, Anand R. Reasons for cancellation of cases on the day of surgery – a prospective study. Indian J Anaesth 2009;53:35–9.
   PubMedGoogle Scholar
• Cancer Incidence in Sweden 2012. The Swedish National Board of Health and Welfare: Stockholm; 2014.
   Google Scholar
• Lissbrant IF, Garmo H, Widmark A, Stattin P. Population-based study on use of chemotherapy in men with castration resistant prostate cancer. Acta Oncol 2013;52:1593–601.
   PubMed Web of Science ®Google Scholar
• Garbay D, Maki RG, Blay JY, Isambert N, Piperno Neumann S, Blay C, et al. Advanced soft-tissue sarcoma in elderly patients: Patterns of care and survival. Ann Oncol 2013; 24:1924–30.
   PubMed Web of Science ®Google Scholar
• >National Guidelines. Swedish Breast Cancer Group 2013.
   Google Scholar
• Goodwin RA, Asmis TR. Overview of systemic therapy for colorectal cancer. Clin Colon Rectal Surg 2009;22: 251–6.
   PubMedGoogle Scholar
• Prezioso D, Galasso R, Di Martino M, Iapicca G, Annunziata E, Iacono F. Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients. Anticancer Res 2007;27:1095–104.
   PubMed Web of Science ®Google Scholar
• Magarotto R, Lunardi G, Coati F, Cassandrini P, Picece V, Ferrighi S, et al. Reduced use of chemotherapy at the end of life in an integrated-care model of oncology and palliative care. Tumori 2011;97:573–7.
   PubMed Web of Science ®Google Scholar
• Saito AM, Landrum MB, Neville BA, Ayanian JZ, Earle CC. The effect on survival of continuing chemotherapy to near death. BMC Palliat Care 2011;10:14.
   PubMed Web of Science ®Google Scholar
• Nakano K, Yoshida T, Furutama J, Sunada S. Quality of end-of-life care for patients with metastatic non-small-cell lung cancer in general wards and palliative care units in Japan. Support Care Cancer 2012;20:883–8.
   PubMed Web of Science ®Google Scholar
• Anshushaug M, Gynnhild MA, Kaasa S, Kvikstad A, Grønberg BH. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncol Epub 2014 Aug 27.
   PubMed Web of Science ®Google Scholar
• Glare P, Sinclair C, Downing M, Stone P, Maltoni M, Vigano A. Predicting survival in patients with advanced disease. Eur J Cancer 2008;44:1146–56.
   PubMed Web of Science ®Google Scholar
• Frigeri M, De Dosso S, Castillo-Fernandez O, Feuerlein K, Neuenschwander H, Saletti P. Chemotherapy in patients with advanced pancreatic cancer: Too close to death? Support Care Cancer 2013;21:157–63.
   PubMed Web of Science ®Google Scholar
• Christakis NA, Lamont EB. Extent and determinants of error in physicians’ prognoses in terminally ill patients: Prospective cohort study. West J Med 2000;172:310–13.
   PubMedGoogle Scholar
• Laird BJ, Kaasa S, McMillan DC, Fallon MT, Hjermstad MJ, Fayers P, et al. Prognostic factors in patients with advanced cancer: A comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res 2013;19:5456–64.
   PubMed Web of Science ®Google Scholar
• Berglund, Å, Byström P, Frödin J-E, Nygren P, Glimelius B. Prognostik, prediktion och behandlingsutvärdering vid cytostatikabehandling av metastatisk colorektal cancer. Annual General Meeting of the Swedish Society of Medicine, 2006.
   Google Scholar
• Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC. Trends in the aggressiveness of end-of-life cancer in the universal health care system of Ontario, Canada. J Clin Oncol 2011;29:1587–91.
   PubMed Web of Science ®Google Scholar
• Randén M, Helde-Frankling M, Runesdotter S, Strang P. Treatment decisions and discontinuation of palliative chemotherapy near the end-of-life, in relation to socioeconomic variables. Acta Oncol 2013;52:1062–6.
   PubMed Web of Science ®Google Scholar
• National guidelines for palliative care. Sweden. 2012–2014. National Board of Health and Welfare: Stockholm; 2014.
   Google Scholar
• Mack JW, Cronin A, Taback N, Huskamp HA, Keating NL, Malin JL, et al. End-of-life care discussions among patients with advanced cancer: A cohort study. Ann Intern Med 2012;156:204–10.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. Practice Guidelines in Oncology. Palliative care. Available from: http://www.nccn.org/professionals/physicians_gls/PDP/palliative.pdf [Cited 13th June 2014].
   Google Scholar